Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Interest Coverage Ratio (2020 - 2022)

Vivos Therapeutics (VVOS) has disclosed Interest Coverage Ratio for 3 consecutive years, with 150.19 as the latest value for Q3 2022.

  • On a quarterly basis, Interest Coverage Ratio rose 74.1% to 150.19 in Q3 2022 year-over-year; TTM through Jun 2023 was 583.11, a 396.32% decrease, with the full-year FY2021 number at 304.36, down 142.68% from a year prior.
  • Interest Coverage Ratio was 150.19 for Q3 2022 at Vivos Therapeutics, up from 188.22 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 2177.44 in Q4 2021 to a low of 4062.0 in Q2 2021.
  • A 3-year average of 635.49 and a median of 174.71 in 2022 define the central range for Interest Coverage Ratio.
  • Biggest YoY gain for Interest Coverage Ratio was 700.08% in 2021; the steepest drop was 5722.38% in 2021.
  • Vivos Therapeutics' Interest Coverage Ratio stood at 362.86 in 2020, then surged by 700.08% to 2177.44 in 2021, then plummeted by 106.9% to 150.19 in 2022.
  • Per Business Quant, the three most recent readings for VVOS's Interest Coverage Ratio are 150.19 (Q3 2022), 188.22 (Q2 2022), and 174.71 (Q1 2022).